Trial intelligence / Profile preview

Diacerein Combined With Febuxostat for Gout

NCT02060552Phase 4Completed

Sponsor
Tongji Hospital
Start
Jan 2013
Primary completion
Mar 2014
Modality
DNA Intercalators/Alkylators
Countries
1
01

Overview

A Phase 4 trial of diacerein in primary gout, sponsored by Tongji Hospital. Started Jan 2013; status: completed.

02

Drugs

diacerein
03

Conditions

primary gout

Beyond the preview

Go deeper on NCT02060552.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02060552.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call